What happens when a trusted safety net for millions of seniors and disabled Americans faces a radical policy shift that could fundamentally alter access to care? A storm of controversy has erupted over a new pilot program by the Centers for Medicare & Medicaid Services (CMS) that introduces prior
I'm thrilled to sit down with James Maitland, a renowned expert in healthcare mergers and acquisitions with a deep understanding of antitrust regulations and their impact on the industry. With years of experience analyzing complex deals, James offers unparalleled insights into how these
Imagine a future where healthcare is not just a trip to the hospital but a seamless experience right in your neighborhood, with services ranging from routine check-ups to urgent care under one roof. The UK’s National Health Service (NHS) is embarking on a groundbreaking journey through its recently
Setting the Stage for Cardiac Device Market Dynamics Imagine a medical technology landscape where innovation saves lives but also demands relentless vigilance to prevent unintended harm, and in 2025, Boston Scientific stands at this critical juncture with its Watchman device, a pioneering solution
Imagine a pivotal government agency tasked with safeguarding public health, suddenly thrust into a storm of political pressure and public scrutiny over its leadership decisions, creating a challenging environment for decision-making. This is the reality for the Food and Drug Administration (FDA) as
Imagine a system where the health of nursing home residents, some of the most vulnerable individuals in society, might be compromised for the sake of corporate profits. This unsettling scenario has come to light with allegations against UnitedHealth, the largest private insurer in the U.S., accused
